Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion

Transfusion

Volumn 54, Issue 2, 2014, Pages 384-388

  Uhlmann, Erik J ^b   Shenoy, Shalini ^a   Goodnough, Lawrence T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX HORMONES; ANEMIA, SICKLE CELL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BLOOD GROUP INCOMPATIBILITY; ERYTHROCYTE TRANSFUSION; HEMOLYSIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; PLASMA EXCHANGE; RECURRENCE; SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84893960248     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12258     Document Type: Article

References (16)

1. Win N, New H, Lee E, de la Fuente J,. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion 2008; 48: 1231-1238.
2. Diamond WJ, Brown FL Jr, Bitterman P, Klein HG, Davey RJ, Winslow RM,. Delayed hemolytic transfusion reaction presenting as sickle-cell crisis. Ann Intern Med 1980; 93: 231-234.
3. Sirchia G, Morelati F, Rebulla P,. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997; 37: 1098-1099.
4. Talano JM, Hillery CA, Gottschall JL, Baylerian DM, Scott JP,. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003; 111: 661-663.
5. Garratty G,. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion 1997; 37: 357-361.
6. King KE, Shirey RS, Lankiewicz MW, Young-Ramsaran J, Ness PM,. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion 1997; 37: 376-381.
7. Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM,. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997; 37: 382-392.
8. Ballas SK, Gay RN,. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997; 37: 1099-1100.
9. Win N, Doughty H, Telfer P, Wild BJ, Pearson TC,. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001; 41: 323-328.
10. Darabi K, Dzik S,. Hyperhemolysis syndrome in anemia of chronic disease. Transfusion 2005; 45: 1930-1933.
11. Win N,. Hyperhemolysis syndrome in sickle cell disease. Expert Rev Hematol 2009; 2: 111-115.
12. Islam MS, Chia L,. Hyperhemolysis syndrome in a patient with sickle cell disease with erythrophagocytosis in peripheral blood. Eur J Haematol 2010; 84: 188.
13. Lu RP, Clark P, Mintz PD,. Hyperhemolysis syndrome: a relative contraindication for transfusion. J Hosp Med 2008; 1: 78-80.
14. Cullis JO, Win N, Dudley JM, Kaye T,. Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction. Vox Sang 1995; 69: 355-357.
15. Bachmeyer C, Maury J, Parrot A, Bachir D, Stankovic K, Girot R, Lionnet F,. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease. Am J Hematol 2010; 85: 91-92.
16. Noizat-Pirenne F, Bachir D, Chadebech P, Michel M, Plonquet A, Lecron JC, Galactéros F, Bierling P,. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease. Haematologica 2007; 92: e132-135.